Open AccessThe Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome
Author(s) -
Alyson Katz,
Diana Altshuler,
John Papadopoulos,
Nancy Amoroso,
Ronald Goldenberg,
Elizabeth S. Tarras,
K. Krolikowski,
Jacklyn Hagedorn,
David Fridman,
Xian Jie Cindy Chen,
Eduardo Iturrate,
Shari B. Brosnahan
Publication year - 2022
Publication title -
annals of pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.926
H-Index - 113
eISSN - 1542-6270
pISSN - 1060-0280
DOI - 10.1177/10600280221094571
Subject(s) - medicine , tocilizumab , covid-19 , acute respiratory distress , respiratory distress , corticosteroid , pharmacology , anesthesia , virology , lung , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom